Brawn Biotech Ltd

₹ 22.7 3.84%

25 Jun - close price

About

Incorporated in 1985, Brawn Biotech Ltd is in the business of trading pharmaceutical products^[1]

Key Points

Business Overview:^[1]
BBL is a fully integrated healthcare company that deals in pharmaceutical products, covering segments:
a) Antibacterial
b) Cardiovascular
c) Antidiabetics
d) Analgesics
e) Gastrointestinal
f) Antifungals
g) Skin Care
h) Antipsychotics,
i) Anti-asthmatics
j) Antacids
k) Antimalarial
l) Nutritional

Website BSE

Market Cap ₹ 6.81 Cr.
Current Price ₹ 22.7
High / Low ₹ 24.4 / 16.7
Stock P/E 7.24
Book Value ₹ 14.5
Dividend Yield 0.00 %
ROCE 0.00 %
ROE 24.4 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.
Company's working capital requirements have reduced from 130 days to 35.9 days

Cons

Promoter holding has decreased over last quarter: -0.45%
The company has delivered a poor sales growth of -13.5% over past five years.
Company has a low return on equity of -14.8% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	4.75	7.29	2.92	2.84	3.45	4.06	3.30	3.84	2.26	5.80	4.89	4.31	1.98
	4.88	7.45	3.31	3.42	3.84	4.56	3.62	4.24	2.81	5.62	4.88	4.32	2.49
Operating Profit	-0.13	-0.16	-0.39	-0.58	-0.39	-0.50	-0.32	-0.40	-0.55	0.18	0.01	-0.01	-0.51
OPM %	-2.74%	-2.19%	-13.36%	-20.42%	-11.30%	-12.32%	-9.70%	-10.42%	-24.34%	3.10%	0.20%	-0.23%	-25.76%
	0.00	0.00	0.00	0.00	0.08	0.00	0.00	0.00	0.09	0.09	0.09	0.09	0.18
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.04	0.02	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03
Profit before tax	-0.17	-0.18	-0.42	-0.61	-0.34	-0.53	-0.35	-0.43	-0.49	0.24	0.07	0.05	-0.36
Tax %	258.82%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-261.11%
	-0.61	-0.17	-0.42	-0.61	-0.34	-0.53	-0.34	-0.43	-0.49	0.24	0.07	0.05	0.58
EPS in Rs	-2.03	-0.57	-1.40	-2.03	-1.13	-1.77	-1.13	-1.43	-1.63	0.80	0.23	0.17	1.93
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	38.65	46.88	59.78	55.71	65.18	49.62	34.98	8.53	22.23	16.49	13.46	16.98
	38.09	45.44	58.53	53.75	64.01	48.89	35.58	10.53	22.53	17.95	15.23	17.31
Operating Profit	0.56	1.44	1.25	1.96	1.17	0.73	-0.60	-2.00	-0.30	-1.46	-1.77	-0.33
OPM %	1.45%	3.07%	2.09%	3.52%	1.80%	1.47%	-1.72%	-23.45%	-1.35%	-8.85%	-13.15%	-1.94%
	0.04	0.01	0.61	0.09	0.74	0.17	0.31	0.00	0.01	0.08	0.09	0.45
Interest	0.10	0.11	0.07	0.06	0.07	0.05	0.04	0.06	0.01	0.06	0.00	0.00
Depreciation	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.05	0.11	0.10	0.11	0.12
Profit before tax	0.47	1.31	1.76	1.96	1.81	0.82	-0.36	-2.11	-0.41	-1.54	-1.79	0.00
Tax %	40.43%	27.48%	20.45%	34.69%	26.52%	28.05%	55.56%	-22.27%	109.76%	-19.48%	-3.35%
	0.28	0.95	1.39	1.28	1.33	0.59	-0.55	-1.64	-0.87	-1.25	-1.74	0.94
EPS in Rs	0.93	3.17	4.63	4.27	4.43	1.97	-1.83	-5.47	-2.90	-4.17	-5.80	3.13
Dividend Payout %	0.00%	31.58%	32.37%	23.44%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	-10%
5 Years:	-13%
3 Years:	-9%
TTM:	26%

Compounded Profit Growth
10 Years:	0%
5 Years:	30%
3 Years:	46%
TTM:	154%

Stock Price CAGR
10 Years:	-4%
5 Years:	3%
3 Years:	15%
1 Year:	40%

Return on Equity
10 Years:	-1%
5 Years:	-16%
3 Years:	-15%
Last Year:	24%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00
Reserves	1.94	2.53	3.92	4.63	5.66	6.26	5.79	4.22	3.31	2.06	0.36	1.34
	0.11	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	8.95	8.30	10.11	14.94	13.85	11.03	5.08	6.56	8.22	9.53	17.13	16.52
Total Liabilities	14.00	13.95	17.03	22.57	22.51	20.29	13.87	13.78	14.53	14.59	20.49	20.86
	0.19	0.24	0.25	0.22	0.19	0.18	0.14	0.39	0.37	0.33	0.46	0.36
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.03	0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	13.78	13.68	16.78	22.35	22.32	20.11	13.73	13.39	14.16	14.26	20.03	20.50
Total Assets	14.00	13.95	17.03	22.57	22.51	20.29	13.87	13.78	14.53	14.59	20.49	20.86

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	0.23	0.05	1.37	-1.54	0.21	-0.08	0.03	0.19	0.32	-0.03	0.05	0.11
	-0.12	-0.08	0.57	0.00	0.00	-0.02	0.00	-0.30	-0.10	-0.01	-0.24	-0.03
	0.00	-0.05	-0.11	-0.06	-0.06	-0.05	-0.04	-0.06	-0.01	0.00	0.00	0.00
Net Cash Flow	0.11	-0.08	1.83	-1.60	0.15	-0.14	0.00	-0.17	0.21	-0.04	-0.20	0.08
Free Cash Flow	0.11	-0.03	1.34	-1.54	0.21	-0.10	0.03	-0.11	0.22	-0.04	-0.19	0.08
CFO/OP	41%	28%	170%	-14%	88%	21%	-52%	-10%	-103%	2%	-3%	-33%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	87.07	71.63	79.50	98.60	92.17	110.34	96.83	120.24	87.35	85.88	92.47	76.31
Inventory Days	11.17	4.50	2.59	2.62	2.12	3.38	3.16	261.82	91.20	153.02	320.33	253.06
Days Payable	73.72	44.59	47.70	83.93	64.58	74.47	32.34	224.66	123.19	144.12	252.10	362.48
Cash Conversion Cycle	24.52	31.54	34.39	17.29	29.72	39.25	67.65	157.41	55.36	94.78	160.70	-33.11
Working Capital Days	15.87	18.92	28.21	43.37	42.06	58.04	77.53	241.76	80.62	137.90	216.40	35.90
ROCE %	11.91%	26.54%	29.28%	27.77%	23.08%	9.71%	-3.55%	-25.61%	-5.91%	-25.86%	-42.52%	0.00%

Insights

In beta

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Number of Permanent Employees
Count

xx	xx	xx	xx	xx	x
x.xx	x.xx	x.xx	x.xx	x.xx	x.xx

Please log in to see hidden values.

Trade Receivable Turnover Ratio
Times

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	53.72%	53.72%	53.72%	53.64%	53.64%	53.64%	53.64%	53.66%	53.66%	53.66%	53.39%	52.94%
	0.59%	0.59%	0.59%	0.35%	0.35%	0.35%	0.35%	0.35%	0.35%	0.35%	0.35%	0.35%
	45.69%	45.69%	45.69%	46.02%	46.02%	46.02%	46.02%	46.01%	46.00%	45.99%	46.27%	46.72%
No. of Shareholders	6,246	6,194	6,139	4,160	4,090	4,157	4,060	4,024	3,975	3,958	3,444	3,303

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	53.68%	53.39%	53.70%	53.71%	53.71%	53.71%	53.72%	53.64%	53.66%	52.94%
	0.59%	0.59%	0.59%	0.59%	0.59%	0.59%	0.59%	0.35%	0.35%	0.35%
	45.73%	46.02%	45.70%	45.69%	45.69%	45.69%	45.69%	46.02%	46.01%	46.72%
No. of Shareholders	6,237	6,219	6,150	6,074	5,991	6,288	6,222	4,160	4,024	3,303

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Brawn Biotech Ltd

Brawn Biotech Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Insights

Shareholding Pattern

Documents

Announcements

Annual reports